Retatrutide is engineered as a single synthetic peptide that simultaneously activates three hormone receptors GLP-1, GIP, and glucagon whereas currently approved medicines target only one or two of these pathways
We'll compare services, costs, and the qualifications of healthcare providers to help you make an informed decision
Master Dosing Conversion Table This single table covers every standard retatrutide dose at the four most common concentrations
Rare but serious side effects ( 10%), including nausea, constipation or diarrhea, loss of appetite/feeling of fullness, and acid reflux
These suggestions come from a multidisciplinary expert panel on dietary changes to manage the GI side effects of GLP-1 medications (Gorgojo-Martnez et al., 2022)